Senior Director Pharmacology

Hélène Dr. Asnagli has over 15 years of experience in international biotech companies, dedicated to development of new therapies in autoimmune diseases.

She obtained her PhD in Immunology from the Centre of Immunology in Marseille, France in 1998 followed by a post-doctoral fellowship at Washington University inSt Louis, Missouri, USA on immunology. This work focused on T cell differentiation at the cellular and molecular levels. She then joined start-up companies in Canada and France, developing cell-based therapies for autoimmune diseases. In 2005, she joined the Immunopharmacology department of Serono, in Ivrea, Italy as head of laboratory working on non-clinical and toxicology projects on antibodies and small-molecules on in in vitro and in vivo models. Starting in 2007, she worked with TxCell in Sophia Antipolis, France where she worked in R&D setting up in vivo models targeting MS, RA, IBD, uveitis, psoriasis and bullous pemphoid indications. For the last 5 years, she was in charge of the non-clinical programs for pharmacology and safety-toxicology studies for FIM and PhII/PhIII clinical programs. She joined Step Pharma in January 2018.